Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (971-980 of 1,161) with videos related to

Pageof 117
Sort By:
JCO Precision Oncology|September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven OncologyJessica J Tao, Michael H Eubank, Alison M Schram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial CancersMin Yuen Teo, Kenneth Seier, Irina Ostrovnaya, et al.
Genome Research|February 27, 2007
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiaeYanhui Hu, Andreas Rolfs, Bhupinder Bhullar, et al.
The Journal of Urology|January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial CarcinomaAditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical FactorsKonrad H Stopsack, Subhiksha Nandakumar, Kanika Arora, et al.
Urologic Oncology|June 4, 2018
Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."M Y Teo, R M Bambury, E C Zabor, et al.
Nature Medicine|July 18, 2017
An approach to suppress the evolution of resistance in BRAF<sup>V600E</sup>-mutant cancerYaohua Xue, Luciano Martelotto, Timour Baslan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial CarcinomaMin Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
Science Translational Medicine|May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaStephen S Chung, Eunhee Kim, Jae H Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for InterventionMaeve A Lowery, Ryan Ptashkin, Emmet Jordan, et al.
Pageof 117

Showing results (971-980 of 1,161) with videos related to

Sort By:
Pageof 117
JCO Precision Oncology|September 11, 2020
Real-World Outcomes of an Automated Physician Support System for Genome-Driven OncologyJessica J Tao, Michael H Eubank, Alison M Schram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2018
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial CancersMin Yuen Teo, Kenneth Seier, Irina Ostrovnaya, et al.
Genome Research|February 27, 2007
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiaeYanhui Hu, Andreas Rolfs, Bhupinder Bhullar, et al.
The Journal of Urology|January 19, 2016
Genomic Biomarkers for the Prediction of Stage and Prognosis of Upper Tract Urothelial CarcinomaAditya Bagrodia, Eugene K Cha, John P Sfakianos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical FactorsKonrad H Stopsack, Subhiksha Nandakumar, Kanika Arora, et al.
Urologic Oncology|June 4, 2018
Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."M Y Teo, R M Bambury, E C Zabor, et al.
Nature Medicine|July 18, 2017
An approach to suppress the evolution of resistance in BRAF<sup>V600E</sup>-mutant cancerYaohua Xue, Luciano Martelotto, Timour Baslan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial CarcinomaMin Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
Science Translational Medicine|May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaStephen S Chung, Eunhee Kim, Jae H Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for InterventionMaeve A Lowery, Ryan Ptashkin, Emmet Jordan, et al.
Pageof 117